INTRODUCTION

55
Cancer is a multistep process, in which genetic alterations have a cumulative effect on the 56 control of cell proliferation, division and growth control. Genetic instability has been 57 prominently implicated in tumor formation. The main evidence comes from the discovery of 58 chromosomal aberrations and mutations of oncogenes or tumor suppressor genes (25). There 59 is experimental evidence that gene alterations can result from viral infection or carcinogenic 60 insult (25).
61
In vivo, among normal epidermis cells, Langerhans cells and melanocytes are not able to 62 proliferate to the contrary of keratinocytes. In vitro, melanocytes can be cultured under 63 highly specific conditions (11). Transformation capabilities of melanocytes are well known 64 in relation to exposure to UV (9). However, a recent study raised doubt about the exclusive In this article, we sought whether exposure to chronic insulin and glucose supplementation 78 could promote melanocyte transformation. To evaluate carcinogenesis, classical criteria 79 were investigated including cell proliferation rate, soft agar colony formation, DNA content, 80 karyotype, oncoprotein expression (PP2A, Akt/PAkt, cMyc, PTEN, PP1 and Ras), PP2A 81 activity which has been shown to be decreased in tumor cells (19) . Metabolic alterations 82 were explored including glycolysis and methyl group metabolism. 83 We found that normal human melanocytes (NHM) exposed to chronic insulin and glucose 84 supplementation display increased proliferation and form colony on soft agar. Also, these 85 cells exhibit increased DNA content, alteration of karyotype, oncoprotein profile changes 86 including increased expression of PP2A, P-Akt and cMyc. In contrast, PP2A methylation 87 and activity were decreased. Transcriptomic data revealed consistent changes in PP2A 88 regulation, Il8 inflammation mediator, and glycolysis. In addition, treated cells exhibited 89 methyl group metabolism redistribution between nucleus and cytoplasm. 90 In conclusion, our data establish that chronic exposure to chronic insulin and glucose lysis buffer and centrifugated (10,000 g, for 10 min at 4°C). The supernatant was added to 166 the cytosolic fraction. The pellet containing nuclei was further disrupted by ultrasonication 9 in fractionation buffer (3 times 15 s in ice) and centrifugated (10,000 g, for 10 min at 4°C). 168 The supernatant was kept as the nuclear fraction. Three independent experiments were performed. (Fig. 1A) . ING cells exposed to 262 concentrations of ×2 to ×10 exhibited shortened doubling time (Table 1) . At ×2 insulin-263 glucose supplementation, the doubling time was 2.7 vs 5.6 days (P<0.01); at ×5 to ×10, the 
Chronic Insulin and Glucose Supplementation Induces Colonies in Soft Agar
276
The ability of insulin-glucose-treated melanocytes to form colonies in soft agar is a classical 277 marker for cell transformation (i.e., these cells display anchorage-independent growth).
278
Several types of cells were tested: untreated human melanocytes (UN), insulin and glucose- despite they were recultured in standard medium for 4 weeks, it may be concluded that the 301 transformed phenotype was acquired during the first 3 weeks of treatment.
302
As shown in Fig. 4A and B, normal melanocytes expressed high levels of PP2AC subunits, 303 both methylated C and non methylated. During exposure to chronic insulin and glucose 304 supplementation, PP2AC expression was increased (+60% and +47%, P<0.05, ING and 305 ING* vs UN, respectively), the methylated C subunit of PP2A was decreased (-42% 306 P<0.05).
307
As a control for PP2A methylation and its consequences on oncoprotein regulation, normal 308 human melanocytes were treated by OA, an antagonist of PP2A. OA inhibited methylation 309 of PP2A (-50%) which up-regulated P-Akt (+30%) and c-Myc (+35%) (Fig. 4C) , showing 310 that inhibiting the activity of PP2A promoted oncogenic changes in melanocytes.
311
The activity of PP2A phosphatase activity was assayed and found to be decreased (-27% and The regulation of oncoproteins and PP2A was investigated by transcriptomics ( The combination of insulin and glucose was used to prevent a possible nutritional cause for 415 impeding proliferation over the long term, and because the phenotype of human melanocytes 416 was expected to become more glycolytic, which was confirmed by transcriptional analysis. inhibition of LCMT1, activation of PME-1, and/or rerouting of SAM metabolism. Table 2 Transcriptomic data of ING* melanocytes in comparison to untreated melanocytes.
